Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma

22 Mar 2014

Abstract excerpt

// Ken Maes 1 , Eva De Smedt 1 , Miguel Lemaire 1 , Hendrik De Raeve 2 , Eline Menu 1 , Els Van Valckenborgh 1 , Steve McClue 3 , Karin Vanderkerken 1,* and Elke De Bruyne 1,* 1 Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium; 2 Department of Pathology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium; 3 Oncology Translational Medicine,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Histone Deacetylase Inhibitors Research
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24833108
DOI: 10.18632/oncotarget.1821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myelomaPMID 24833108Read ↗

Understanding DNA Damage Response and DNA Repair in Multiple MyelomaSemantic proximity Read ↗

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma TherapySemantic proximity Read ↗

DNA Damage Response and Oxidative Stress in the Resistance of Multiple Myeloma Cells to Genotoxic TreatmentSemantic proximity Read ↗

DNA repair pathways in human multiple myelomaSemantic proximity Read ↗

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple MyelomaSemantic proximity Read ↗

The role of epigenetics in the biology of multiple myelomaSemantic proximity Read ↗

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?Semantic proximity Read ↗

The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapseSemantic proximity Read ↗

Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectivesSemantic proximity Read ↗

Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell SurvivalSemantic proximity Read ↗

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cellsSemantic proximity Read ↗

DNA Damage Response in Multiple Myeloma: The Role of the Tumor MicroenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.